Nakatsu, Japan

Tomio Muro

This inventor holds 5 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1976-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Nakatsu, JA (1976 - 1977)
  • Nakatsu, JP (1983 - 1991)

Company Filing History:


Years Active: 1976-1991

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Tomio Muro

Introduction

Tomio Muro is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antihypertensive properties. With a total of 5 patents to his name, Muro's work has had a considerable impact on medical science.

Latest Patents

Muro's latest patents include innovative compounds such as trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds. These compounds are designed to improve coronary, cerebral, and kidney circulation, making them valuable as antihypertensive agents. The detailed formula of these compounds showcases their complexity and potential for treating circulatory diseases.

Career Highlights

Muro is currently associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to advance his research and development efforts. His work focuses on creating effective treatments for hypertension and related circulatory issues, contributing to the overall health and well-being of patients.

Collaborations

Throughout his career, Muro has collaborated with esteemed colleagues such as Kiyoshi Ogawa and Yasuaki Chihara. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic agents.

Conclusion

Tomio Muro's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving health outcomes. His work continues to influence the development of effective treatments for hypertension and circulatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…